3 Einträge gefunden

1. Secukinumab 2-weekly vs. 4-weekly dosing in patients with plaque-type psoriasis: results from the randomized GAIN study

   1. Reich, K
   2. Körber, A
   3. Mrowietz, U
   4. Sticherling, M
   5. Sieder, C
   6. Früh, J
   7. Bachhuber, T

   2021 - Forschungsinformationssystem des UKE
2. Secukinumab is effective in treatment of moderate-to-severe plaque psoriasis: real-life effectiveness and safety from the PROSPECT study

   1. Thaçi, D
   2. Körber, A
   3. von Kiedrowski, R
   4. Bachhuber, T
   5. Melzer, N
   6. Kasparek, T
   7. Duetting, E

   2020 - Forschungsinformationssystem des UKE
3. Secukinumab treatment of moderate to severe plaque psoriasis in routine clinical care: real-life data of prior and concomitant use of psoriasis treatments from the PROSPECT study

   1. Körber, A
   2. Thaçi, D
   3. von Kiedrowski, R
   4. Bachhuber, T
   5. Melzer, N
   6. Kasparek, T
   7. Kraehn-Senftleben, G

   2018 - Forschungsinformationssystem des UKE